Literature DB >> 1311289

Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane protein.

P M Vestlev, G Pallesen, K Sandvej, S J Hamilton-Dutoit, S M Bendtzen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1311289     DOI： 10.1002/ijc.2910500432

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  10 in total

1.  Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases.

Authors:  M Engel; M F Essop; P Close; P Hartley; G Pallesen; C Sinclair-Smith
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

2.  Association of Hodgkin's lymphoma with Epstein Barr virus infection.

Authors:  Elmir Cickusić; Jasminka Mustedanagić-Mujanović; Ermina Iljazović; Zinaida Karasalihović; Ina Skaljić
Journal:  Bosn J Basic Med Sci       Date:  2007-02       Impact factor: 3.363

3.  Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies--a prospective study.

Authors:  T Lehtinen; J Lumio; J Dillner; M Hakama; P Knekt; M Lehtinen; L Teppo; P Leinikki
Journal:  Cancer Causes Control       Date:  1993-05       Impact factor: 2.506

4.  The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood.

Authors:  A Claviez; M Tiemann; J Peters; H Kreipe; R Schneppenheim; R Parwaresch
Journal:  Ann Hematol       Date:  1994-02       Impact factor: 3.673

5.  CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients.

Authors:  Katherine Antel; D Chetty; J Oosthuizen; Z Mohamed; L Van der Vyver; E Verburgh
Journal:  Pathology       Date:  2021-02-06       Impact factor: 5.335

6.  Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.

Authors:  M Glavina-Durdov; J Jakic-Razumovic; V Capkun; P Murray
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

7.  Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function.

Authors:  U Axdorph; A Porwit-MacDonald; J Sjöberg; G Grimfors; M Ekman; W Wang; P Biberfeld; M Björkholm
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

8.  Impact of Tumour Epstein-Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL.

Authors:  Mahdi Nohtani; Katerina Vrzalikova; Maha Ibrahim; Judith E Powell; Éanna Fennell; Susan Morgan; Richard Grundy; Keith McCarthy; Sarah Dewberry; Jan Bouchal; Katerina Bouchalova; Pamela Kearns; Paul G Murray
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

9.  Prognostic significance of EBV latent membrane protein 1 expression in lymphomas: evidence from 15 studies.

Authors:  Yuan Mao; Mei Ping Lu; Hong Lin; Da Wei Zhang; Ying Liu; Qing Dong Li; Zhi Gang Lv; Jia Ren Xu; Ren Jie Chen; Jin Zhu
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

10.  The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma.

Authors:  Hikmet Gulsah Tanyildiz; Inci Yildiz; Nuray Bassullu; Nukhet Tuzuner; Alp Ozkan; Tiraje Celkan; Hilmi Apak
Journal:  Iran J Pediatr       Date:  2015-12-23       Impact factor: 0.364
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.